Fast and easy cardiovascular diagnosis for everyone. Phantomics turns cardiac MRI and CT into standardized, one-click analysis so every hospital can offer expert-level care.
Myomics®
A fully automated, AI-driven cardiac MRI solution
From segmentation to report generation in one click. Function, T1/T2 mapping, tissue characterization, flow and perfusion.
Learn more
Angiomics®
AI-driven triage for coronary stenosis
Effortless triage for acute chest pain. Deep learning detects significant stenosis on coronary CT angiography in minutes.
Learn more
Cardiovascular disease is the leading cause of death worldwide. Cardiac MRI and CT are essential for early diagnosis, yet long imaging times and the need for advanced expertise keep them out of reach for many patients. Phantomics lowers those barriers with standardized AI, creating a win-win ecosystem for clinicians and patients.

Phantomics acts as a virtual assistant that autonomously delivers the essential diagnostic information physicians need, so they can focus on decisions rather than manual contouring.
Analysis that used to take 30 minutes or more is completed in a few minutes, with results evaluated automatically against reference ranges.
Phantom-based standardization and automated quantification reduce inter-site variability, so results are comparable wherever the scan was taken.
U.S. FDA 510(k) clearance, Korea MFDS, Japan PMDA, Taiwan, Thailand and Malaysia approvals, EN ISO 13485 certification and 20+ peer-reviewed publications.
Phantomics has obtained Class 3 digital medical device manufacturing approval from Korea's MFDS for Angiomics ER, coronary CT stenosis diagnostic-support software that helps prioritize care for emergency chest-pain patients.
Read morePhantomics, a leading medical imaging AI company (CEOs Byungwook Choi and Pan Kim), has signed a strategic partnership agreement with Philmedis Clinic (Director Namsik Jung) for research collaboration based on cardiac MRI.Through this agreement, Phantomics sec
Read moreStrategic MOU aims to enhance clinical accuracy and real-world application of heart disease AIPhantomics, a South Korean medical AI company, has signed a memorandum of understanding (MOU) with Yonsei University’s School of Digital Healthcare to jointly develop
Read moreRequest a demo, discuss a clinical study or explore a partnership. Our team in Seoul and Boston will get back to you.